KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Depreciation & Amortization (CF) (2017 - 2025)

Elanco Animal Health's Depreciation & Amortization (CF) history spans 9 years, with the latest figure at $174.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 6.1% year-over-year to $174.0 million; the TTM value through Dec 2025 reached $680.0 million, up 2.72%, while the annual FY2025 figure was $680.0 million, 2.72% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $174.0 million at Elanco Animal Health, down from $176.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $202.0 million in Q1 2021 and bottomed at $161.0 million in Q1 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $170.5 million (2021), against an average of $171.7 million.
  • The largest YoY upside for Depreciation & Amortization (CF) was 146.34% in 2021 against a maximum downside of 21.62% in 2021.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $174.0 million in 2021, then decreased by 3.45% to $168.0 million in 2022, then rose by 1.79% to $171.0 million in 2023, then dropped by 4.09% to $164.0 million in 2024, then grew by 6.1% to $174.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Depreciation & Amortization (CF) are $174.0 million (Q4 2025), $176.0 million (Q3 2025), and $169.0 million (Q2 2025).